BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 9192542)

  • 21. Antipsychotic medication in children and adolescents: a descriptive review of the effects on prolactin level and associated side effects.
    Roke Y; van Harten PN; Boot AM; Buitelaar JK
    J Child Adolesc Psychopharmacol; 2009 Aug; 19(4):403-14. PubMed ID: 19702492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Switching female schizophrenic patients to quetiapine from conventional antipsychotic drugs: effects on hyperprolactinemia.
    Nakajima M; Terao T; Iwata N; Nakamura J
    Pharmacopsychiatry; 2005 Jan; 38(1):17-9. PubMed ID: 15706461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperprolactinemia in a patient with a pituitary adenoma receiving antipsychotic drug therapy.
    Carroll RW; Christodoulou P; Baynes KC; Kahn DA
    J Psychiatr Pract; 2012 Mar; 18(2):126-9. PubMed ID: 22418404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of the dopamine agonists bromocriptine and cabergoline in the management of risperidone-induced hyperprolactinemia in patients with psychotic disorders.
    Tollin SR
    J Endocrinol Invest; 2000 Dec; 23(11):765-70. PubMed ID: 11194712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antipsychotic-induced hyperprolactinemia and sexual dysfunction.
    Compton MT; Miller AH
    Psychopharmacol Bull; 2002; 36(1):143-64. PubMed ID: 12397853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risperidone-induced symptomatic hyperprolactinaemia in adolescents.
    Holzer L; Eap CB
    J Clin Psychopharmacol; 2006 Apr; 26(2):167-71. PubMed ID: 16633146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated prolactin in pediatric patients on typical and atypical antipsychotics.
    Wudarsky M; Nicolson R; Hamburger SD; Spechler L; Gochman P; Bedwell J; Lenane MC; Rapoport JL
    J Child Adolesc Psychopharmacol; 1999; 9(4):239-45. PubMed ID: 10630453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case of delayed galactorrhoea as an adverse event of overlapping haloperidol and clozapine administration.
    Conca A; Waler M; Walpoth M; König P; Hausmann A
    Int J Neuropsychopharmacol; 2005 Jun; 8(2):303-5. PubMed ID: 15850503
    [No Abstract]   [Full Text] [Related]  

  • 29. Hyperprolactinemia Secondary to Pituitary Microadenoma Versus Haloperidol- A Diagnostic Enigma. A Case Report and Brief Review.
    Madhusoodanan S; Steinberg LR; Coleman A; Bavli S
    Curr Drug Saf; 2017; 12(1):19-21. PubMed ID: 27440143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Higher serum concentrations of tyrosine and glutamate in schizophrenia patients treated with clozapine, compared to in those treated with conventional antipsychotics.
    Melkersson K; Lewitt M; Hall K
    Neuro Endocrinol Lett; 2015; 36(5):465-80. PubMed ID: 26707048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Minimal effects of JL 13, a pyridobenzoxazepine derivative with an antipsychotic potential, on circulating prolactin levels in male rats.
    Liégeois JF; Bruhwyler J; Hendrick JC; Delarge J; Legros JJ; Damas J
    Neurosci Lett; 2002 Feb; 319(1):49-52. PubMed ID: 11814651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential add-on effects of aripiprazole in resolving hyperprolactinemia induced by risperidone in comparison to benzamide antipsychotics.
    Chen CK; Huang YS; Ree SC; Hsiao CC
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Dec; 34(8):1495-9. PubMed ID: 20732372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risperidone-induced galactorrhea associated with a prolactin elevation.
    Popli A; Gupta S; Rangwani SR
    Ann Clin Psychiatry; 1998 Mar; 10(1):31-3. PubMed ID: 9622047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relationship between prolactin levels and glucose homeostasis in antipsychotic-treated schizophrenic patients.
    Howes OD; Smith S; Gaughran FP; Amiel SA; Murray RM; Pilowsky LS
    J Clin Psychopharmacol; 2006 Dec; 26(6):629-31. PubMed ID: 17110820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Verapamil-induced hyperprolactinemia--a case report].
    Krysiak R; Okopieh B; Herman ZS
    Pol Arch Med Wewn; 2005 Feb; 113(2):155-8. PubMed ID: 16209236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aripiprazole for the Management of Antipsychotic-Induced Hyperprolactinemia A Retrospective Case Series.
    Yeager A; Shad MU
    Prim Care Companion CNS Disord; 2020 Jan; 22(1):. PubMed ID: 31999895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Failure of bromocriptine to suppress prolactin in majeptil-induced hyperprolactinemia.
    Yarkoni S; Spitz IM; Ben-David M; Polishuk WZ
    Acta Eur Fertil; 1978 Dec; 9(4):185-8. PubMed ID: 573042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Drug treatment of schizophrenic psychoses in puerperium].
    Olbrich HM; Martin P
    Nervenarzt; 1994 Jul; 65(7):482-5. PubMed ID: 7800093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A case of sibutramine-induced hyperprolactinemia.
    Soares Leaes CG; Pereira-Lima JF; da Costa Oliveira M
    Neuro Endocrinol Lett; 2011; 32(5):616-8. PubMed ID: 22167128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A 30-year-old woman with galactorrhea.
    Ray I; Jones RM
    CMAJ; 2020 Apr; 192(15):E397-E398. PubMed ID: 32392501
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.